← Back to Search

Clinical Prediction Model for COPD

N/A

Recruiting

Research Sponsored by University of British Columbia

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Have a diagnosis of COPD

Aged 35 years and older

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 year before and 1 year after initial study visit.

Awards & highlights

Study Summary

This trial will study if a tool that predicts the risk of lung attacks for people with COPD results in better care and patient satisfaction.

Who is the study for?

This trial is for Canadian residents aged 35 or older who have been diagnosed with Chronic Obstructive Pulmonary Disease (COPD) and can communicate in English. It's not open to those under the age of 35.Check my eligibility

What is being tested?

The study tests a digital tool called ACCEPT, integrated into electronic health records, to predict COPD patients' risk of lung attacks and improve personalized care at two hospitals in Vancouver, BC.See study design

What are the potential side effects?

Since this trial involves a prediction tool rather than medication, traditional side effects are not applicable. However, there may be indirect impacts on patient care based on the tool's recommendations.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with COPD.

Select...

I am 35 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 year before and 1 year after initial study visit.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 year before and 1 year after initial study visit.

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year before and 1 year after initial study visit. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Prescription appropriateness

Secondary outcome measures

COPD patient's Quality of Life

Impact of COPD on patient's daily life

Medication adherence

+2 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: ACCEPT Decision InterventionExperimental Treatment1 Intervention

Clinical prediction model (ACCEPT)-based treatment recommendations: The ACCEPT tool will display the predicted risk of exacerbations, and the corresponding treatment recommendations to the physicians. These recommendations will be provided in a non-mandatory 'directive' format where the physician can override the recommendation, but is required to provide a justification (pre-set choices and a free text).

Group II: Usual care (Control)Active Control1 Intervention

Routine COPD patient care.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Providence Health & ServicesOTHER

117 Previous Clinical Trials

821,405 Total Patients Enrolled

Vancouver Coastal HealthOTHER_GOV

37 Previous Clinical Trials

710,782 Total Patients Enrolled

University of British ColumbiaLead Sponsor

1,418 Previous Clinical Trials

2,465,988 Total Patients Enrolled

Media Library

ACCEPT Decision Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05309356 — N/A

Chronic Obstructive Pulmonary Disease Research Study Groups: Usual care (Control), ACCEPT Decision Intervention

Chronic Obstructive Pulmonary Disease Clinical Trial 2023: ACCEPT Decision Intervention Highlights & Side Effects. Trial Name: NCT05309356 — N/A

ACCEPT Decision Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05309356 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there currently any participants being admitted to this trial?

"Per the information presented on clinicaltrials.gov, this study does not presently have spots available for participants. This research project was initially posted in January 1st of 2023 and most recently modified March 31st 2022. At present, 477 other medical trials are actively seeking patients to enroll in them."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Using Clinical Prediction Models to Improve Treatment for Patients With Chronic Obstructive Pulmonary Disease (COPD)

Mohsen Sadatsafavi 2023. "Using Clinical Prediction Models to Improve Treatment for Patients With Chronic Obstructive Pulmonary Disease (COPD)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05309356.

All > Copd